[C677T genetic polymorphism of methylenetetrahydrofolate reductase in premature coronary heart disease]

Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 1999 Apr;21(2):118-21.
[Article in Chinese]

Abstract

Objective: Methylenetetrahydrofolate reductase (MTHFR) is an important factor responsible for hyperhomocysteinemia. The relation of MTHFR gene C677T polymorphism and premature coronary heart disease was studied.

Methods: MTHFR C677T genetic polymorphisms in 67 patients with premature coronary heart disease were detected by PCR-RFLP technique.

Results: In case group, the frequency of T homogenic type was 34.3% (23/67), heterogenic type 43.3% (29/67) and C homogenic type 22.4% (15/67). T allele frequency was 55.9% (75/134) while C allele frequency 44.1% (59/134) in case group. There were significant differences in MTHFR genotype and allele frequencies between cases and controls (chi 2 = 6.82 and 5.41 respectively, P < 0.05).

Conclusions: It was suggested that MTHFR gene C677T mutation was a possible risk factor of Chinese premature coronary heart disease.

Publication types

  • English Abstract

MeSH terms

  • Adult
  • Alleles
  • Coronary Disease / genetics*
  • Female
  • Gene Frequency
  • Genotype
  • Humans
  • Male
  • Methylenetetrahydrofolate Reductase (NADPH2)
  • Middle Aged
  • Oxidoreductases Acting on CH-NH Group Donors / genetics*
  • Point Mutation
  • Polymerase Chain Reaction
  • Polymorphism, Restriction Fragment Length*

Substances

  • Oxidoreductases Acting on CH-NH Group Donors
  • Methylenetetrahydrofolate Reductase (NADPH2)